Health
Committee activity related to implementation of the Affordable Care Act; health insurance company practices; Medicare and Medicaid; prescription drugs; chronic and infectious diseases; reproductive and women’s health; and the safety of America’s food supply.
More on Health
Hearing on "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances"
The Subcommittee on Health of the Committee on Energy and Commerce will hold a hybrid hearing that includes both in-person and remote attendance on Thursday, December 2, 2021, at 10:30 a.m. This hearing will take place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances."
Livestream
The Committee on Energy and Commerce met in a hybrid open markup session on Wednesday, November 17, 2021, at 10:30 a.m. This markup took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing.
Key Documents
Memorandum from Chairman Pallone to the Full Committee
Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released the following statement today after the Centers for Medicare & Medicaid Services (CMS) announced that Medicare Part B premiums paid by beneficiaries will increase next year, and attributed the increase largely to the rise in prescription drug costs:
Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released the following statement on President Biden’s nomination of Robert Califf, M.D., to serve as Commissioner of the Food and Drug Administration (FDA):
“Dr. Califf is a proven leader who will bring a wealth of knowledge and expertise upon his return to the agency.